Suppr超能文献

巨噬细胞迁移抑制因子作为一种伴侣蛋白抑制错误折叠的超氧化物歧化酶1的积累。

Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.

作者信息

Israelson Adrian, Ditsworth Dara, Sun Shuying, Song SungWon, Liang Jason, Hruska-Plochan Marian, McAlonis-Downes Melissa, Abu-Hamad Salah, Zoltsman Guy, Shani Tom, Maldonado Marcus, Bui Anh, Navarro Michael, Zhou Huilin, Marsala Martin, Kaspar Brian K, Da Cruz Sandrine, Cleveland Don W

机构信息

Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel.

Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093-0670, USA; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0670, USA.

出版信息

Neuron. 2015 Apr 8;86(1):218-32. doi: 10.1016/j.neuron.2015.02.034. Epub 2015 Mar 19.

Abstract

Mutations in superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by loss of motor neurons and accompanied by accumulation of misfolded SOD1 onto the cytoplasmic faces of intracellular organelles, including mitochondria and the endoplasmic reticulum (ER). Using inhibition of misfolded SOD1 deposition onto mitochondria as an assay, a chaperone activity abundant in nonneuronal tissues is now purified and identified to be the multifunctional macrophage migration inhibitory factor (MIF), whose activities include an ATP-independent protein folding chaperone. Purified MIF is shown to directly inhibit mutant SOD1 misfolding. Elevating MIF in neuronal cells suppresses accumulation of misfolded SOD1 and its association with mitochondria and the ER and extends survival of mutant SOD1-expressing motor neurons. Accumulated MIF protein is identified to be low in motor neurons, implicating correspondingly low chaperone activity as a component of vulnerability to mutant SOD1 misfolding and supporting therapies to enhance intracellular MIF chaperone activity.

摘要

超氧化物歧化酶(SOD1)的突变会导致肌萎缩侧索硬化症(ALS),这是一种神经退行性疾病,其特征是运动神经元丧失,并伴有错误折叠的SOD1在细胞内细胞器(包括线粒体和内质网(ER))的细胞质面上积累。以抑制错误折叠的SOD1在线粒体上的沉积为检测方法,一种在非神经组织中丰富的分子伴侣活性现已被纯化并鉴定为多功能巨噬细胞迁移抑制因子(MIF),其活性包括一种不依赖ATP的蛋白质折叠分子伴侣。纯化的MIF被证明可直接抑制突变型SOD1的错误折叠。在神经元细胞中提高MIF水平可抑制错误折叠的SOD1的积累及其与线粒体和内质网的关联,并延长表达突变型SOD1的运动神经元的存活时间。已确定运动神经元中积累的MIF蛋白含量较低,这意味着相应较低的分子伴侣活性是易受突变型SOD1错误折叠影响的一个因素,并支持增强细胞内MIF分子伴侣活性的疗法。

相似文献

1
Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.
Neuron. 2015 Apr 8;86(1):218-32. doi: 10.1016/j.neuron.2015.02.034. Epub 2015 Mar 19.
2
Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10198-203. doi: 10.1073/pnas.1604600113. Epub 2016 Aug 22.
3
AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14755-14760. doi: 10.1073/pnas.1904665116. Epub 2019 Jul 1.
4
Macrophage migration inhibitory factor as a component of selective vulnerability of motor neurons in ALS.
Rare Dis. 2015 Jun 17;3(1):e1061164. doi: 10.1080/21675511.2015.1061164. eCollection 2015.
7
Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Cell Rep Med. 2024 May 21;5(5):101546. doi: 10.1016/j.xcrm.2024.101546. Epub 2024 May 3.
10
The inhibitory effects of MIF on accumulation of canine degenerative myelopathy-associated mutant SOD1 aggregation.
Res Vet Sci. 2022 Oct;147:7-11. doi: 10.1016/j.rvsc.2022.03.013. Epub 2022 Mar 17.

引用本文的文献

4
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration.
Biomolecules. 2024 Dec 30;15(1):33. doi: 10.3390/biom15010033.
5
Protocol for handling and using SOD1 mice for amyotrophic lateral sclerosis pre-clinical studies.
STAR Protoc. 2024 Dec 20;5(4):103459. doi: 10.1016/j.xpro.2024.103459. Epub 2024 Nov 22.
6
Translational challenges in amyotrophic lateral sclerosis therapy with macrophage migration inhibitory factor.
Neural Regen Res. 2025 Sep 1;20(9):2583-2584. doi: 10.4103/NRR.NRR-D-24-00616. Epub 2024 Sep 24.
8
Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review.
Neurooncol Adv. 2024 Aug 10;6(1):vdae142. doi: 10.1093/noajnl/vdae142. eCollection 2024 Jan-Dec.
9
Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Cell Rep Med. 2024 May 21;5(5):101546. doi: 10.1016/j.xcrm.2024.101546. Epub 2024 May 3.

本文引用的文献

1
Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.
Acta Neuropathol Commun. 2014 May 14;2:55. doi: 10.1186/2051-5960-2-55.
2
Molecular basis of nitrate uptake by the plant nitrate transporter NRT1.1.
Nature. 2014 Mar 6;507(7490):68-72. doi: 10.1038/nature13116. Epub 2014 Feb 26.
3
Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms.
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3620-5. doi: 10.1073/pnas.1312245111. Epub 2014 Feb 18.
4
Necroptosis drives motor neuron death in models of both sporadic and familial ALS.
Neuron. 2014 Mar 5;81(5):1001-1008. doi: 10.1016/j.neuron.2014.01.011. Epub 2014 Feb 6.
5
Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.
Neuron. 2014 Jan 22;81(2):333-48. doi: 10.1016/j.neuron.2013.12.009.
7
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS.
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):829-32. doi: 10.1073/pnas.1314085111. Epub 2013 Dec 30.
10
Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis.
Neuromolecular Med. 2013 Mar;15(1):147-58. doi: 10.1007/s12017-012-8204-z. Epub 2012 Oct 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验